Prathiba M Singh, advocate for Ranbaxy and Cipla, fought the Glivec patent case against Novartis. She joined IBNLive readers for an interaction on the legal and moral compulsions behind this courtroom battle and the significance of the Supreme Court's decision for Indian pharma firms and the people of the country. ...
06:33 PM, Apr 03, 2013
Shares of the Swiss pharmaceutical giant Novartis fell about 4.5 per cent on Monday after the Supreme Court of India dismissed its plea for a patent on its cancer drug, Gelvic. Shares of select Indian pharmaceutical companies rallied as the industry is set to receive a boost following the verdict. ...
11:48 AM, Apr 01, 2013
Dr. Yusuf K Hamied of Cipla Limited was awarded the CNN-IBN Indian of The Year 2012 in the business category. ...
12:22 PM, Dec 17, 2012
Bangalore: Drug-maker Cipla on Thursday said it has appointed Subhanu Saxena as the Chief Executive Officer of the company. The appointment is effective from February 1, 2013. Saxena has more than 25 years of work experience. He has worked with companies such as Citicorp, The Boston Consulting Group and PepsiCo, across markets in Europe, North America, Africa and Asia, Cipla said in a statement. In his last assignment, Saxena led...
09:16 AM, Nov 22, 2012
New Delhi: Drug major Cipla on Tuesday said it has launched 'Qvir', a four-drug kit priced at Rs 158 per kit to be used for treating HIV/AIDS. The kit consists of two tablets packaged together in one strip which represents a single day's treatment, Cipla said in a statement. Commenting on the introduction Cipla Chairman and Managing Director YK Hamied said: "While we are committed to making drugs affordable and...
05:37 PM, Aug 14, 2012
Mumbai: A Parliamentary committee has uncovered a nexus between doctors, government bodies and pharmacy companies to approve new drugs without the mandatory clinical trials. The doctors from top hospitals wrote to the country's Drug Controller General, to allow new drugs to be marketed, without clinical trials - a shocking lapse, highlighted in this Parliamentary standing committee report. Drug expert CM Gulati said, "All of them are compromised. We've got the...
06:16 AM, May 14, 2012
Mumbai: After the Indian government recently lifted a patent license, Indian pharma major, Cipla, has announced a massive reduction of up to 76 per cent in its cancer drug prices. Following the move, the price of Cipla's generic kidney cancer drug, Sorafenib, will be available at Rs 6,840 a month from the earlier Rs 27,950. The lung cancer drug Gestinib price has been cut down by 60 per cent to...
07:51 AM, May 05, 2012
Cipla, Ranbaxy, Hetero, Roche and Natco Pharma are in the race. ...
12:37 AM, Aug 13, 2009
The Ambani groups have gained maximum benefit in stocks last week. ...
03:07 PM, May 25, 2009
Kolkata: South African skipper Graeme Smith says his team has encountered vastly varying pitches in the cricket World Cup and the experience was likely to stretch on as they take on Bangladesh in the last group league game in Dhaka on Saturday. However, he sees no problem in adapting to the varying tracks. Referring to the Eden Gardens track on Tuesday night when his side crushed Ireland by 131 runs...
11:13 PM, Jan 02, 2008
The TN govt has sent a notice to a magazine for publishing i-pill ads. ...
03:35 AM, Aug 22, 2007
The i-pill is showing contra-indications in Tamil Nadu. ...
08:45 PM, Aug 21, 2007
Cipla has launched an HIV/AIDS drug that could be taken once a day by the patients for effective treatment. ...
03:51 PM, Oct 13, 2006
